Rainbow Childrens Medicare Q2 FY27 Share Price & Earnings Call Analysis

₹1,218.70+1.83% today
Market cap
₹12,377 Cr
P/E
43.20
ROE
15.90%
PEG
7.76
Price to sales
6.81
Debt to equity
0.54
52W high / low
₹1,599 / ₹1,104
Sales growth (5Y)
21.24%
EBITDA margin
31.60%
Net profit margin
14.72%
Promoter holding
49.83%
Sales (last year)
₹1,820 Cr

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]

Guidance scorecard · Q2 FY27 call

What Rainbow Childrens Medicare Ltd's management guided
and where it ranks in Healthcare Services

#11of 33 in
Healthcare Services

RevenueQ1 FY27 call

20–40%
  • Revenue growth target is around 20% annually, aiming to double revenue over approximately 4 years.
  • Current trajectory expects revenue to cross INR 2,000 crores by the end of the financial year and double in the next four years.
  • Volume growth supported by planned addition of 2,500 beds over 5 years (~15% CAGR).
  • New Bengaluru hospitals expected to breakeven within 12-15 months, all within about 18 months.
  • Acquisitions in Andhra Pradesh (Nellore, Guntur) expected to stabilize in 6 months and contribute positively to cluster performance by year-end.

2 more points from Rainbow Childrens Medicare Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what Rainbow Childrens Medicare Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Invested approximately INR 56 crores towards capital expenditure during the quarter, primarily focused on expanding and strengthening capabilities across existing hospitals and upcoming projects.
  • Planning to add around 2,500 beds over the next five years as part of capacity expansion.
  • Ongoing capital expenditure program funded through strong internal accruals and a robust balance sheet with cash and investments totaling INR 613 crores as of June 30, 2026.
  • Exploring and executing acquisitions and greenfield projects in new markets including Mumbai, Noida, Central India, Bhubaneswar, and Raipur to broaden presence.
  • Focus on building hub-and-spoke networks for operational efficiency and clinical strength.

2 more points from Rainbow Childrens Medicare Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Rainbow Childrens Medicare Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

Ask what Rainbow Childrens Medicare Ltd said on the order book →

Full Q1 FY27 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. 3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹903 Cr—
240%+Flat₹583 Cr22.2
3Aster DM Quality Care Ltd20–40%Up 2%+₹58,782 Cr162.9
420–40%Up 0–2%₹1,730 Cr17.5
520–40%Up 0–2%₹580 Cr11.9
620–40%Flat₹1.13L Cr53.9

Sign up free to see every company in the sector ranking and track Rainbow Childrens Medicare Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

Financials of Rainbow Childrens Medicare Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Rainbow Childrens Medicare Ltd

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +49.83%49.83%49.87%49.85%49.85%49.85%49.85%49.85%49.84%49.84%49.84%49.83%
FIIs +22.32%24.04%24.78%25.12%25.12%23.69%23.60%21.85%19.24%17.24%16.03%14.66%
DIIs +15.62%14.76%13.81%13.84%13.87%15.31%15.44%17.46%19.49%21.12%22.56%23.28%
Public +12.23%11.37%11.53%11.20%11.16%11.14%11.11%10.82%11.40%11.68%11.39%11.84%
Others +0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.04%0.12%0.18%0.40%
No. of Shareholders80,47177,15278,55777,52478,76479,09280,32081,13488,80988,56189,30592,814

Financials of Rainbow Childrens Medicare Ltd

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +333336341330417398370353445445460470548
Expenses +215218236236270264255249296298315335378
Operating Profit11811810694147134115104149147145135170
OPM %35%35%31%28%35%34%31%29%33%33%31%29%31%
Other Income +891312111315208114138
Interest13141718181818181920202122
Depreciation27283234353534343640414245
Profit before tax85856953105947771102988784112
Tax %26%26%26%26%25%27%27%25%26%24%10%26%25%
Net Profit +63635140796957547674786384
EPS in Rs6.206.125.023.897.776.765.555.277.417.147.595.968.08

Financials of Rainbow Childrens Medicare Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +1692343214025437196509741,1741,2971,5161,7031,923
Expenses +1282042663323915194856667748651,0221,1551,327
Operating Profit41305569151201165308400432494548596
OPM %24%13%17%17%28%28%25%32%34%33%33%32%31%
Other Income +1016111081010193137514235
Interest3334424846565863778284
Depreciation91822286069738390112138151167
Profit before tax38244147589356187282295330358380
Tax %35%28%24%22%22%41%29%26%25%26%26%21%
Net Profit +25173136455540139212218244282299
EPS in Rs3.342.284.234.135.076.344.5514.7020.7721.3823.9727.4028.77
Dividend Payout %7%11%7%12%10%16%0%14%14%14%13%13%

Financials of Rainbow Childrens Medicare Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital9994444444494102102102102
Reserves1662753083073173503914989581,1571,3671,547
Borrowings +22242624476501529592570765764891
Other Liabilities +3441557389123116112140146145236
Total Liabilities2313493994489261,0191,0811,2961,7712,1702,3772,775
Fixed Assets +781231742967027027728589311,2531,3981,756
CWIP3531712234329623202879
Investments7260310182258308571404
Other Assets +111194212140199265262409759590380535
Total Assets2313493994489261,0191,0811,2961,7712,1702,3772,775

Financials of Rainbow Childrens Medicare Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +26173648127170143224329321396420
Cash from Investing Activity +-20-107-33-42-117-117-83-175-465-226-268-259
Cash from Financing Activity +-793-1-7-9-52-61-44143-102-118-147
Net Cash Flow-131-222-147-71014
Free Cash Flow-35-46-21-103429667162188-32250204
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit95%88%79%88%94%95%102%93%103%95%97%95%

Financials of Rainbow Childrens Medicare Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days111016142422251516201922
Inventory Days393548363255362843535267
Days Payable121107142151197202190121182180170162
Cash Conversion Cycle-72-62-79-100-141-124-130-78-123-107-100-73
Working Capital Days-35-36-28-31-26-18-17-167343198
ROCE %22%11%14%14%16%16%11%23%24%19%19%17%

Guidance history

How Rainbow Childrens Medicare Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →20–40%FlatPlanned——
Q4 FY26 call →10–20%FlatPlannedNone planned—
Q3 FY26 call →10–20%FlatPlanned——
Q2 FY26 call →20–40%FlatPlanned——

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

22out of 100

Momentum score · price trend

22 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−11.7%48%
Last 6 months−2.7%52%
Last 3 months−20.1%22%

The price is 26.1% below its all-time high of ₹1,649.75 (14 Nov 2024). Stocks more than 20% below their peak have their score halved, so 44 became 22.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Rainbow Childrens Medicare Ltd: 0.4 × 48 + 0.4 × 52 + 0.2 × 22 = 44, halved to 22 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Healthcare Services this season

  • Narayana Hrudayalaya Ltd (Q2 FY27)

    Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27

  • Artemis Medicare Services Ltd (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service

  • Max Healthcare Institute Ltd (Q2 FY27)

    Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio

  • Indegene Ltd (Q2 FY27)

    Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo